Cavatica will, for the first time, allow doctors, researchers and data scientistsunparalleled access to pediatric brain tumor genomic data paired with a suite of analysistools in a cloud computing environment that enables scalable, faster and more robustresearch. Upon its full release, Cavatica will host the largest standardized, integrated,and quality-controlled genomic database of pediatric brain cancer genomic data.

Working with Seven Bridges, a biomedical data analysis company, the eight CBTTC sitemembers and 15 member hospitals of PNOC are further fulfilling their commitmentearlier this year to the White House Precision Medicine Initiative (PMI) with the launchof the Beta version of Cavatica being announced today. The Beta release will be openfor subscribed end-user input and will be iteratively enhanced by ongoingimplementation of advanced platform features and deposition of additional data setsover the coming months. These datasets will include additional pediatric cancersupporting pan-cancer pediatric data analysis in partnership with additional consortiaincluding the SU2C-St. Baldrick's Pediatric Cancer Dream Team.

Sign up for access to the Beta release of Cavatica is available for researchers and datascientists by going to cavatica.org.

For more information or to schedule an interview, please contact the CBTTC at
This email address is being protected from spambots. You need JavaScript enabled to view it.